AbbVie (NYSE: ABBV) reported third-quarter 2020 financial results before the regular trading hours on Friday. The pharmaceutical behemoth reported Q3 revenue of $12.9 billion, which surpassed the Wall Street consensus. Net earnings of $2.83 per share were also better than the target that analysts had projected.
ABBV shares gained 1.4% immediately following the announcement. The stock has slipped 10% since the beginning of this year.
AbbVie’s flagship arthritis drug Humira reported net revenues of $5.140 billion, which was 4% more than last year. While sales increased 7.7% in the US, international markets saw a 9% decrease due to competition from biosimilars.
Video game retailer GameStop Corp. (NYSE: GME), which has become the talk of the town after the unprecedented stock rally in recent weeks, reported a narrower loss for the first
The steel industry managed to shrug off the pandemic blues earlier than expected as the recovery in industrial activity pushed up demand. With the vaccination drive and the government’s aggressive
Campbell Soup Company (NYSE: CPB) reported third-quarter 2021 earnings results today. Net sales decreased 11% year-over-year to $1.98 billion, as a result of lapping the demand surge at the onset